Pronova Laboratories wins prestigious CPhI Worldwide Award for most innovative OTC medical device

Frankfurt, 2017 – Pronova Laboratories has been awarded the CPhI Worldwide Award for the most innovative OTC medical device during the CPhI trade fair in Frankfurt. The award was granted for Forwarts, an advanced wart treatment product distinguished by its unique technology.

The award was granted for our innovative wart treatment product, Forwarts, which is distinguished by our uniquely developed technology. Forwarts uses a patented valve system that delivers a precisely targeted stream of cooling gas directly onto the wart. This direct spray method is a true step forward in wart cryotherapy, replacing the traditional foam applicator with a faster, more accurate, and more effective treatment.

At the exhibition, we showcased Forwarts to an international audience and proudly celebrated this recognition. Winning this award strengthens Pronova’s position as a leader in innovative self-care solutions and highlights our commitment to setting new standards in healthcare..

CPhI Worldwide is the largest pharmaceutical trade fair in the world, bringing together over 60,000 professionals and 2,500 exhibitors each year. The CPhI Awards shine a spotlight on breakthrough products that redefine quality and effectiveness in the industry. We are honored that Forwarts now stands among them.

For Pronova, this achievement continues a tradition of innovation. Back in 1997, we introduced Wartner, the first successful OTC wart cryotherapy product for home use. With Forwarts, we are once again reshaping the market—making treatments more effective, more accessible, and easier to use. The success of Forwarts suggests that Pronova may once again be on the path to reshaping the OTC market with a new standard in effectiveness and ease of use.